Table 2.
DNMT inhibitors ongoing clinical trials
| Medication | Condition | Phase | Clinical Trial | Other drugs |
|---|---|---|---|---|
| Azacitidine | Acute Myeloid Leukemia Acute Myelogenous Leukemia |
Phase 2 | NCT01358734 | Lenalidomide |
| Leukemia AML MDS |
Phase 3 | NCT00887068 | ||
| Prostate Cancer | Phase I/II | NCT00503984 | Docetaxel Prednisone |
|
| Acute Myeloid Leukemia | Phase II | NCT00492401 | ||
| Decitabine | Metastatic Papillary Thyroid Cancer Follicular Thyroid Cancer |
Phase II | NCT00085293 | |
| Acute Myeloid Leukemia | Phase II | NCT00492401 | ||
| Sickle Cell Disease | Phase 1 | NCT01685515 | THU | |
| Colon cancer | Interventional | NCT01882660 | ||
| Myelodysplastic Syndromes Acute Myeloid Leukemia |
Phase 4 | NCT01806116 |